Evidence map›Paper›PMID 42802182›Full record

ArticleNature communications2026

Psilocybin enhances sociability only in altered behavioural state and does not need an awake experience to be effective.

Chenchen Song, Tinya Chang, Tobias Buchborn, Thomas Knöpfel

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chenchen SongLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. chenchen.song@ntu.edu.sg.ORCID http://orcid.org/0000-0003-4574-6431
Tinya ChangLaboratory for Neuronal Circuit Dynamics, Imperial College London, London, UK.ORCID http://orcid.org/0009-0003-2650-803X
Tobias BuchbornLaboratory for Neuronal Circuit Dynamics, Imperial College London, London, UK.
Thomas KnöpfelLaboratory for Neuronal Circuit Dynamics, Imperial College London, London, UK. tknopfel@knopfel-lab.net.ORCID http://orcid.org/0000-0002-5718-0765

Funding

MOH | National Medical Research Council (NMRC) MOH-001720
6 · The paper itself

Abstract

Psilocybin, a psychoactive compound contained in certain mushrooms, can provoke profound psychedelic experiences and also exerts established and controversial therapeutic efficacy in clinical depression and other neuropsychiatric conditions respectively. Here we report that a single systemic administration of the serotonergic psychedelic psilocybin can durably promote social behaviour in the Cntnap2-knockout mouse model of autism spectrum disorder (ASD), while no increase in sociability is observed in isogenic control mice. Addressing the concern that the therapeutic actions of psilocybin may involve potentially adverse psychedelic effects, we tested drug application in anesthetised mice and found that awake brain states are not required for psilocybin's sociability enhancing actions in ASD mice.

Indexed as

Autism Spectrum DisorderBehavior, AnimalHallucinogensPsilocybinSocial BehaviorWakefulnessAnimalsBrainDisease Models, AnimalMaleMiceMice, Inbred C57BLMice, KnockoutNerve Tissue ProteinsHallucinogensNerve Tissue ProteinsPsilocybin

Identifiers

PMID42802182
PMCPMC13616899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.